Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta - Wikidata - awgldk - TriplyDB

Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta

Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta

http://www.wikidata.org/entity/Q35049491

about

The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsia An exploratory study into the role of miR-204-5p in pregnancy-induced hypertension Predisposing Factors to Abnormal First Trimester Placentation and the Impact on Fetal Outcomes Microvascular endothelial cells from preeclamptic women exhibit altered expression of angiogenic and vasopressor factors.sFLT-1 inhibits proliferation, migration, and invasion of colorectal cancer SW480 cells through vascular mimicry formation suppression.Use of serum and urinary soluble sFlt-1 and PLGF in the diagnosis of preeclampsia.Bone Marrow-Derived Endothelial Progenitor Cells Reduce Recurrent Miscarriage in Gestation.Angiogenic Factors produced by Hypoxic Cells are a leading driver of Anastomoses in Sprouting Angiogenesis-a computational study.

P2860

Q26798193-BF883584-6980-479E-BD5B-D799E14F4958 Q33724115-A2CAE395-BAB6-43A6-92A7-14663AA2EAA5 Q37131377-EC2932EA-7D75-4402-9B5B-8319E4578179 Q46308383-9F671542-5717-4F61-AC42-9F13B09931EF Q51022245-06C10DD4-A9A2-4319-990A-0CD08055AE72 Q51332754-D970774E-9E92-46D7-8DE2-2EA7642FD96C Q51577960-BC1AE716-FEE6-4576-AC56-AC13B02F954D Q55280508-49F7C034-6B18-47E8-B47C-30A6F18CB9ED

P2860

Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta

http://www.wikidata.org/entity/Q35049491

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta

@ast

Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta

@en

type

label

Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta

@ast

Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta

@en

prefLabel

Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta

@ast

Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta

@en

P1433

Q35049491-72069CE3-38D3-49D3-8FA8-F12805A4701D

P1476

Q35049491-C0D6BB0D-6FBF-4D8D-9D9C-D83896A2B53F

P2093

Q35049491-140C0620-8436-456B-ABAF-4E14A9E7745D

Q35049491-74A06E19-2ABC-4CAD-9629-D4014D40DCDC

P2860

Q35049491-0ABA65F8-4388-4F6B-B062-B2BAC21FF677

Q35049491-1B2ED521-597C-43D4-8EAB-F079C862B664

Q35049491-1F96EDBE-3F59-4F89-906F-50ABBAB9F131

Q35049491-2B9F3045-EDF4-4E19-9DAC-F5966A50744A

Q35049491-3BC54AF8-0DD9-495C-A5EF-F9700DA641FE

Q35049491-57A2B6EB-58E9-491B-BBE5-F1B355196A9C

Q35049491-619F3AF3-3789-46E6-BF4D-F345EFC8EE42

Q35049491-63832036-D84E-4C29-BA06-0B9DC8F9E432

Q35049491-6BE522E0-161B-4BD6-A802-CC49FDA9CF0A

Q35049491-79F03C32-A810-47D5-A0AD-6716DED84CFC

P304

Q35049491-0ECECF75-BEE9-482A-BE29-167B8BCEDB89

P31

Q35049491-B0BDF6AF-0902-48B7-A584-572524B230C9

P356

Q35049491-AFEF9FA3-A5EF-479F-8187-B7EA66C762EA

P407

Q35049491-09D5351E-4979-4B6E-9121-C2E400863881

P433

Q35049491-74085CF1-D459-40C8-98CA-47AF7A2360E0

P478

Q35049491-5FA132CD-967F-4362-8517-4B094B06E456

P50

Q35049491-FEF97476-50AF-4249-9D9D-FBE9E1901046

P577

Q35049491-31F80887-DC4E-4A97-8D12-8D3FB25A373D

P5875

Q35049491-3A94B31E-8490-4CC0-96CA-361290694ACA

P698

Q35049491-180695A5-2489-4371-ACCB-0D65C90D1B7D

P932

Q35049491-A870D194-BA4F-4FDD-B34F-A4123400EC00

P356

JOURNAL.PONE.0081176

P1433

P1476

Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta

@en

P2093

Dennis K Lee

http://www.w3.org/2001/XMLSchema#string

Ori Nevo

http://www.w3.org/2001/XMLSchema#string

P2860

Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

Identification of a new endothelial cell growth factor receptor tyrosine kinase

Mtd/Bok takes a swing: proapoptotic Mtd/Bok regulates trophoblast cell proliferation during human placental development and in preeclampsia

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies.

ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.

A novel Mtd splice isoform is responsible for trophoblast cell death in pre-eclampsia.

Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome.

Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure.

P304

e81176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0081176

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Isabella Caniggia

P577

2013-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258826133

http://www.w3.org/2001/XMLSchema#string

P698

24260556

http://www.w3.org/2001/XMLSchema#string

P932

3834253

http://www.w3.org/2001/XMLSchema#string